• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

NDI-091143

CAS No. 2375840-87-0

NDI-091143 ( —— )

产品货号. M20771 CAS No. 2375840-87-0

NDI-091143 is a potent and high-affinity human ATP-citrate lyase (ACLY) inhibitor with an IC50 of 2.1 nM (ADP-Glo assay)indirectly disrupting citrate binding via an unexpected mechanism of inhibition.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥324 有现货
5MG ¥494 有现货
10MG ¥818 有现货
25MG ¥1677 有现货
50MG ¥2989 有现货
100MG ¥3191 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    NDI-091143
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    NDI-091143 is a potent and high-affinity human ATP-citrate lyase (ACLY) inhibitor with an IC50 of 2.1 nM (ADP-Glo assay)indirectly disrupting citrate binding via an unexpected mechanism of inhibition.
  • 产品描述
    NDI-091143 is a potent and high-affinity human ATP-citrate lyase (ACLY) inhibitor with an IC50 of 2.1 nM (ADP-Glo assay)indirectly disrupting citrate binding via an unexpected mechanism of inhibition.
  • 同义词
    ——
  • 通路
    Endocrinology/Hormones
  • 靶点
    ATPase
  • 受体
    ACLY
  • 研究领域
    Cancer
  • 适应症
    ——

化学信息

  • CAS Number
    2375840-87-0
  • 分子量
    453.8
  • 分子式
    C20H14ClF2NO5S?
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO:91 mg/mL (200.51 mM)
  • SMILES
    COC(=O)c1cc(Cl)c(O)c(S(=O)(=O)Nc2cc(-c3ccccc3)c(F)cc2F)c1
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Jia Wei Silvana et al. An allosteric mechanism for potent inhibition of human ATP-citrate lyase[J]. Nature 2019.
产品手册
关联产品
  • Wilforine

    Wilforine is a sesquiterpene pyridine alkaloid; important bioactive compound in T. wilfordii plants and is effective in treating idiopathic pulmonary fibrosis.

  • Trichlormethiazide

    Trichlormethiazide is a thiazide diuretic with properties similar to those of hydrochlorothiazide.

  • Thevetin B

    Thevetin B is a cardiac glycoside. Thevetin A and thevetin B are Na+-, K+-dependent adenosinetriphosphatase (Na+,K+-ATPase) (EC 3.6.1.3) inhibitors.